Navina, the health tech company that uses AI to produce patient medical history summaries for doctors, has raised $22 million.
The financing was led by Alive Israel Healthtech fund, with participation from existing investors, doubling the total investment to date to $44 million.
The Israeli company’s AI presents doctors with an easy-to-read patient profile that can be accessed through a smartphone app. It includes indications of risk factors, illnesses, and treatments of a patient, so that physicians do not need to sift through records going back months and years from different hospitals and specialists.
In the past year, Navina (“Together we understand” in Hebrew) expanded its platform to include not only physicians but also their supporting staff, improving the overall level of care in health clinics.
Navina’s real-world effectiveness was validated by a recent report issued by the Innovation Lab of the American Academy of Family Physicians, which found that the platform increases diagnosis accuracy, as well reduces pre-visit preparation time by 61 percent.
“Our mission, from the beginning, has been to give physicians the time and confidence they need to stay ahead of their patients’ health, and to transform the physician-patient interaction, changing it from reactive to proactive,” said Ronen Lavi, Co-founder and CEO of Navina.
“As Israel’s top health tech fund, whose leaders are former directors of the country’s largest hospitals and medical centers and accomplished investors, Alive is the ideal partner for this journey.”
Shay Perera, Co-founder and CTO, said: “Our investors recognize that AI can enable primary-care doctors to practice medicine the way they desire, while empowering physician groups and health systems to achieve the economics that enable them to meet their responsibilities to the community.”
Lavi and Perera are two former intelligence officers who revolutionized the use of AI during their time in the IDF to present military commanders with the data they needed, when they needed it.
Navina was founded in 2018, and is based in Tel Aviv.